Overview

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

Status:
Terminated
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectivess of a single intramuscular injection of peramivir for the treatment of subjects with acute, uncomplicated influenza.
Phase:
Phase 3
Details
Lead Sponsor:
BioCryst Pharmaceuticals
Treatments:
Peramivir